Polymorphism at position-308 of TNFalfa gene influences outcome of infliximab therapy in rheumatoid arthritis

被引：0
|
作者：
Mugnierl, B [1 ]
Balandraud, N [1 ]
Roudier, C [1 ]
Roudier, J [1 ]
Reviron, D [1 ]
机构：
[1] INSERM, EMI 9940, F-13258 Marseille, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [1] Polymorphism at position-308 of the tumor necrosis factor a gene influences outcome of infliximab therapy in rheumatoid arthritis
    Mugnier, B
    Balandraud, N
    Darque, A
    Roudier, C
    Roudier, J
    Reviron, D
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (07): : 1849 - 1852
  • [2] Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
    Mugnier, B
    Reviron, D
    Darque, A
    Balandraud, N
    Roudier, C
    Roudier, J
    [J]. ARTHRITIS RESEARCH & THERAPY, 2004, 6 (Suppl 1) : S23 - S24
  • [3] Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
    B Mugnier
    D Reviron
    A Darque
    N Balandraud
    C Roudier
    J Roudier
    [J]. Arthritis Res Ther, 6
  • [4] Polymorphism at position-308 of the promoter of the tumor necrosis factor α gene and infliximab therapy in rheumatoid arthritis.
    Fonseca, JE
    Carvalho, T
    Cruz, M
    Nero, P
    Sobral, M
    Mourao, AF
    Cavaleiro, J
    Carmo-Fonseca, M
    Branco, J
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S394 - S394
  • [5] Polymorphism at position-308 of the tumour necrosis factor α gene and rheumatoid arthritis pharmacogenetics
    Fonseca, JE
    Carvalho, T
    Cruz, M
    Nero, P
    Sobral, M
    Mourao, AF
    Cavaleiro, J
    Ligeiro, D
    Abreu, I
    Carmo-Fonseca, M
    Branco, JC
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) : 793 - 794
  • [6] Polymorphism atposition-308of TNFagene influences response to infliximab therapy in rheumatoid arthritis.
    Mugnier, B
    Reviron, D
    Balandraud, N
    Roudier, C
    Roudier, J
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S129 - S129
  • [7] Polymorphism at position-174 of the interleukin-6 gene influences outcome of etanercept therapy in rheumatoid arthritis
    Arsenovic-Ranin, N.
    Jancic, I.
    Sefik-Bukilica, M.
    Zivojinovic, S.
    Damjanov, N.
    Spasovski, V.
    Srzentic, S.
    Stankovic, B.
    Pavlovic, S.
    [J]. IMMUNOLOGY, 2012, 137 : 24 - 24
  • [8] No association of the TNF alpha gene polymorphism in position-308 with susceptibility to MS
    Biernacka-Lukanty, Justyna
    Michalowska-Wender, Grazyna
    Wender, Mieczyslaw
    [J]. PHARMACOLOGICAL REPORTS, 2011, 63 (05) : 1286 - 1286
  • [9] No association of the TNF alpha gene polymorphism in position-308 with susceptibility to MS
    Justyna Biernacka-Łukanty
    Grażyna Michałowska-Wender
    Mieczysław Wender
    [J]. Pharmacological Reports, 2011, 63 : 1286 - 1286
  • [10] -308 A/G polymorphism in the tumor necrosis factor-A gene influences outcome of etanercept treatment in rheumatoid arthritis
    Guis, S.
    Balandraud, N.
    Bouvenot, J.
    Auger, I.
    Toussirot, E.
    Wendling, D.
    Mattei, J. P.
    Thomachot, B.
    Legeron, P.
    Mugnier, B.
    Landt, O.
    Roudier, J.
    Roudier, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 149 - 149
12345